Double-blind, placebo-controlled, non-inferiority study to evaluate the cognitive and neuropsychological effects of levetiracetam 20-60 mg/kg/day as adjunctive treatment versus placebo in pediatric patients with partial-onset seizures

被引：0
|
作者：
Mintz, Mark [1 ]
Hunter, S. [2 ]
Yang, H.
Schiemann, J. [3 ]
Jones, J. [3 ]
Stalvey, T. [3 ]
机构：
[1] Clin Res Ctr New Jersey, Ctr Neurol & Neurodev Hlth, Voorhees, NJ USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] UCB Inc, Smyma, GA USA
来源：
EPILEPSIA | 2007年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [1] Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized double-blind, placeboc controlled, non-inferiority study
    Levisohn, P. M.
    Hunter, S. J.
    Yang, H.
    Schiemann, J.
    Jones, J.
    Stalvey, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 84 - 85
  • [2] Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures
    Glauser, T. A.
    Ayala, R.
    Elterman, R. D.
    Mitchell, W. G.
    Van Orman, C. B.
    Gauer, L. J.
    Lu, Z.
    NEUROLOGY, 2006, 66 (11) : 1654 - 1660
  • [3] Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: A randomized, double-blind, placebo-controlled, noninferiority trial
    Levisohn, Paul M.
    Mintz, Mark
    Hunter, Scott J.
    Yang, Haichen
    Jones, John
    EPILEPSIA, 2009, 50 (11) : 2377 - 2389
  • [4] Multicenter, double-blind, placebo-controlled trial of adjunctive levetiracetam (Keppra®) therapy (up to 60 mg/kg/day) in pediatric patients with refractory partial epilepsy
    Glauser, TA
    Gauer, LJ
    Chen, L
    EPILEPSIA, 2004, 45 : 186 - 186
  • [5] A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures
    Halford, Jonathan J.
    Ben-Menachem, Elinor
    Kwan, Patrick
    Ness, Seth
    Schmitt, Jennifer
    Eerdekens, Marielle
    Novak, Gerald
    EPILEPSIA, 2011, 52 (04) : 816 - 825
  • [6] Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: A double-blind, randomized, placebo-controlled trial
    Peltola, Jukka
    Coetzee, Christo
    Jimenez, Fiacro
    Litovchenko, Tetyana
    Ramaratnam, Sridharan
    Zaslavaskiy, Leonid
    Lu, Zhihong
    Sykes, Deanne M.
    EPILEPSIA, 2009, 50 (03) : 406 - 414
  • [7] YKP3089 IN PARTIAL-ONSET SEIZURES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    French, J. A.
    Kowalski, J.
    Maciejowski, M.
    Ilankumaran, P.
    Kamin, M.
    EPILEPSIA, 2014, 55 : 19 - 19
  • [8] Double-blind, placebo-controlled trial of retigabine as adjunctive therapy in partial-onset seizures: Gender subset analysis
    Mansbach, Hank
    Li, Y.
    EPILEPSIA, 2007, 48 : 338 - 339
  • [9] Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study
    Hong, Zhen
    Inoue, Yushi
    Liao, Weiping
    Meng, Hongmei
    Wang, Xuefeng
    Wang, Wenmin
    Zhou, Liemin
    Zhang, Liming
    Du, Xinlu
    Tennigkeit, Frank
    EPILEPSY RESEARCH, 2016, 127 : 267 - 275
  • [10] A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures
    Biton, Victor
    Krauss, Gregory
    Vasquez-Santana, Blanca
    Bibbiani, Francesco
    Mann, Allison
    Perdomo, Carlos
    Narurkar, Milind
    EPILEPSIA, 2011, 52 (02) : 234 - 242
12345